Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18–30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial
作者
Shi Liwei,Xiaowei Gao,Lili Huang,Zhao Gao,Juan Li,Bang‐Wei Yu,H W Fan,Guohua Li,Yanxia Wang,Qi Li,Lin Yuan,Changgui Li,Zhaojun Mo